VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Thursday, January 1, 2026

Stock Comparison

Abbott Laboratories vs Parker-Hannifin Corporation

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Abbott Laboratories

ABT · New York Stock Exchange

Market cap (USD)$219.2B
SectorHealthcare
CountryUS
Data as of2025-12-30
Moat score
64/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.

View ABT analysis

Parker-Hannifin Corporation

PH · New York Stock Exchange

Market cap (USD)$111.4B
SectorIndustrials
CountryUS
Data as of2025-12-31
Moat score
71/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Parker-Hannifin Corporation's moat claims, evidence, and risks.

View PH analysis

Comparison highlights

  • Moat score gap: Parker-Hannifin Corporation leads (71 / 100 vs 64 / 100 for Abbott Laboratories).
  • Segment focus: Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices); Parker-Hannifin Corporation has 2 segments (68.8% in Diversified Industrial).
  • Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
  • Moat breadth: Abbott Laboratories has 10 moat types across 3 domains; Parker-Hannifin Corporation has 5 across 2.

Primary market context

Abbott Laboratories

Cardiovascular & Electrophysiology Devices

Market

Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices

Geography

Global

Customer

Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists

Role

Implantable device manufacturer

Revenue share

26.7%

Parker-Hannifin Corporation

Diversified Industrial

Market

Motion and control components & systems (industrial and mobile applications)

Geography

Global

Customer

OEMs and industrial distributors/aftermarket channels

Role

Component and system designer/manufacturer with aftermarket support

Revenue share

68.8%

Side-by-side metrics

Abbott Laboratories
Parker-Hannifin Corporation
Ticker / Exchange
ABT - New York Stock Exchange
PH - New York Stock Exchange
Market cap (USD)
$219.2B
$111.4B
Sector
Healthcare
Industrials
HQ country
US
US
Primary segment
Cardiovascular & Electrophysiology Devices
Diversified Industrial
Market structure
Oligopoly
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
64 / 100
71 / 100
Moat domains
Demand, Legal, Supply
Supply, Demand
Last update
2025-12-30
2025-12-31

Moat coverage

Shared moat types

Installed Base ConsumablesDistribution Control

Abbott Laboratories strengths

Brand TrustProcurement InertiaData Workflow LockinGovernment Contracting RelationshipsCompliance AdvantageScale Economies Unit CostTraining Org Change CostsIP Choke Point

Parker-Hannifin Corporation strengths

Design In QualificationScope EconomiesOperational Excellence

Segment mix

Abbott Laboratories segments

Full profile >

Established Pharmaceutical Products

Competitive

12.4%

Diagnostic Products

Oligopoly

22.3%

Pediatric Nutrition

Oligopoly

9.6%

Adult Nutrition

Oligopoly

10.5%

Diabetes Care (CGM & glucose monitoring)

Duopoly

16.2%

Cardiovascular & Electrophysiology Devices

Oligopoly

26.7%

Neuromodulation Devices

Oligopoly

2.3%

Parker-Hannifin Corporation segments

Full profile >

Diversified Industrial

Competitive

68.8%

Aerospace Systems

Oligopoly

31.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.